Clinical trial

Antibody and Delayed Cyclosporine Versus Initial Cyclosporine Alone in Patients…

NCT00007787 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed

Key facts

NCT number NCT00007787
Title Antibody and Delayed Cyclosporine Versus Initial Cyclosporine Alone in Patients Receiving Kidney Transplants
Official title Evaluation of Antibody Plus Delayed CSA vs CSA in Determining Delayed Graft Function in Cadaver Transplant Recipients
Lead sponsor National Institute of Allergy and Infectious Diseases (NIAID), NIH
Status Completed
Study type Interventional
Conditions Kidney Transplantation, Chronic Allograft Nephropathy
Intervention type Biological, Drug
Interventions Cyclosporine, Anti-human thymocyte globulin (rabbit), Tacrolimus
Enrollment 350
Start date Apr 1, 2000
Completion Mar 1, 2004
First posted Aug 31, 2001
Last update posted Jan 23, 2013
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies